Relugolix Recruiting Phase 3 Trials for Endometriosis related pain Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03204318SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
NCT03204331SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain